FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
F/M Emerald Life Sciences Innovation ETF Stock AnalysisComprehensive stock analysis for F/M Emerald Life Sciences Innovation ETF (LFSC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLFSC
LFSC
F/M Emerald Life Sciences Innovation ETF
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
LFSC
Home🔹Stocks🔹F/M Emerald Life Sciences Innovation ETF

F/M Emerald Life Sciences Innovation ETF

LFSC•NASDAQ

F/M Emerald Life Sciences Innovation ETF

LFSC•NASDAQ
Market cap
$122.62M
Sentiment

Your view on LFSC

Mkt Cap
$122.62M
Sentiment
Your view
LFSC
F/M Emerald Life Sciences Innovation ETF
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
LFSC
Company Overview

Overview

What the company does, where it operates, and who runs it.

About F/M Emerald Life Sciences Innovation ETF

Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
US
Industry
Asset Management
Sector
Financial Services
CEO
Not available
Headquarters
US
Description

LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News